vimarsana.com
Home
Live Updates
Hansa Biopharma half year report 2023 (1) : vimarsana.com
Hansa Biopharma half year report 2023 (1) : vimarsana.com
Hansa Biopharma half year report 2023 (1)
LUND, Sweden, July 20, 2023 /PRNewswire/ -- Hansa Biopharma, the pioneer in immunomodulatory enzyme...
Related Keywords
France ,
United Kingdom ,
Finland ,
Sweden ,
Australia ,
United States ,
Belgium ,
Berlin ,
Germany ,
Netherlands ,
American ,
Australian ,
Donato Spota ,
Matthew Shaulis ,
Adrian Schreiber ,
Philipp Enghard ,
Stephanie Kenney ,
Prnewswire Hansa Biopharma ,
Klaus Sindahl ,
Hansa Biopharma ,
Australian Therapeutic Goods Administration ,
American Society Of Gene ,
Acceptable Mismatch Program ,
Acceptable Mismatch ,
American Society ,
Cell Therapy Conference ,
Duchenne Muscular ,
Lead Nicer ,
Crigler Najjar Phase ,
Report January ,
Thursday July ,
Securities Markets ,
Investor Relationsm ,
Corporate Affairsm ,